descartes-15
descartes-15: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Phase 3 |
Clinical Trials (1)
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
Frequently asked questions
Who is developing descartes-15?
descartes-15 is being developed by Cartesian Therapeutics, Inc..
How many clinical trials involve descartes-15?
BioSniper tracks 1 clinical trial involving descartes-15.
Get deeper analysis on descartes-15
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis